FDA recall record

Dexcom G4 PLATINUM (Pediatric) Receiver Receiver Part Number: MT22430 Receiver (mg/dL) recall — FDA Z-1335-2016

Customers may not receive an intended audible alarm or alert if relying on hearing the alarm or alert.

Class Iclassification
Z-1335-2016official record ID
Apr 20, 2016report date

Recall record at a glance

Official recordZ-1335-2016
CategoryMedical Device Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmDexcom Inc.
Report dateApr 20, 2016
Recall initiation dateFeb 23, 2016
Quantity18,004
LocationSan Diego, CA, United States

Official product description

Dexcom G4 PLATINUM (Pediatric) Receiver Receiver Part Number: MT22430 Receiver (mg/dL), Black (pediatrics); MT22430-PNK, Receiver (mg/dL), Pink (pediatrics); MT22430-BLU, Receiver (mg/dL); Blue (pediatrics). Intended to detect trends and track glucose patterns in persons with diabetes.

Why the product was recalled

Customers may not receive an intended audible alarm or alert if relying on hearing the alarm or alert.

Distribution information

Worldwide Distribution-US (nationwide), Canada, Italy, Netherlands, Belgium, Norway, New Zealand, Poland, Sweden, Denmark, Slovenia, Turkey, South Africa, India, Israel, Hungary, Hong Kong, UK, Ireland, France, Finland, Spain, Portugal, Colombia, Chile, Germany, Austria, Switzerland, Kuwait, United Arab Emirates, Australia, Czech Republic, Bahrain, Lebanon, and Qatar.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceMay 20, 2026

Dexcom G7 CGM watchOS App recall — FDA Z-2164-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceMay 20, 2026

Dexcom G7 CGM iOS App recall — FDA Z-2163-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceMay 20, 2026

Dexcom ONE+ iOS CGM App recall — FDA Z-2165-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceSep 10, 2025

Dexcom G7 CGM Android App recall — FDA Z-2446-2025

The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System…

Class IFDA: OngoingDexcom, Inc.